Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare
Aligos Therapeutics Inc. Cash on Hand 2020–2025
Aligos Therapeutics Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Aligos Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 18.3M, a 50.53% decrease year-over-year.
- Aligos Therapeutics Inc. cash on hand for 2025 were 18.3M, a 50.53% decrease from 2024.
- Aligos Therapeutics Inc. cash on hand for 2024 were 37.0M, a 72.74% decrease from 2023.
- Aligos Therapeutics Inc. cash on hand for 2023 were 135.7M, a 66.82% increase from 2022.
- Aligos Therapeutics Inc. cash on hand for 2022 were 81.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aligos Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $18 |
| 2024 | $37 |
| 2023 | $136 |
| 2022 | $81 |
| 2021 | $187 |
| 2020 | $220 |
| Aligos Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $18 |
| 2024-12-31 | $37 |
| 2023-12-31 | $136 |
| 2022-12-31 | $81 |
| 2021-12-31 | $187 |
| 2020-12-31 | $220 |
Aligos Therapeutics Inc. Cash on Hand — FAQ
Aligos Therapeutics Inc. (ALGS) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALGS's cash on hand history?
The chart and table above show Aligos Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.